Related topics

Amarin: 3Q Earnings Snapshot

November 5, 2019

DUBLIN (AP) _ Amarin Corp. PLC (AMRN) on Tuesday reported a loss of $3.5 million in its third quarter.

On a per-share basis, the Dublin-based company said it had a loss of 1 cent. Earnings, adjusted for stock option expense, were 1 cent per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 1 cent per share.

The biopharmaceutical company posted revenue of $112.4 million in the period, missing Street forecasts. Five analysts surveyed by Zacks expected $112.6 million.

Amarin expects full-year revenue in the range of $380 million to $420 million.

Amarin shares have increased 28% since the beginning of the year. The stock has declined 24% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMRN at https://www.zacks.com/ap/AMRN